AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUNIC, INC. Director's Dealing 2025

Jun 20, 2025

Director's Dealing

Opens in your device viewer

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2025-06-05

Reporting Person: Nash Duane (Director, Executive Chairman)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-05	Stock Option	$0.7729	A	570000	Acquired	2035-06-05	Common Stock (570000)	Direct

F1: The option vests in monthly increments over a period of one year from the grant date.